John A. Ormiston - Concepedia

Author

John A. Ormiston

Also Known As

J A Ormiston, J Ormiston, J. A. ORMISTON, J. A. Ormiston, J. Ormiston, J.A. Ormiston, JOHN A. ORMISTON, Joachim Schofer, John A Ormiston, John A. Ormiston

329

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

Auckland City Hospital Mercy Angiography Unit Mercy Hospital Erasmus University Rotterdam St Vincent's Hospital Melbourne

About

John A. Ormiston is an author at Auckland City Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	63	6.5K
2	Engineering	21	23	2.1K
3	Public Health	16	16	2.2K
4	Health Sciences	5	5	285
5	Applied Physiology	2	2	50

John A. Ormiston

137

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma, The Lancet Percutaneous Coronary InterventionCardiovascular Translational ResearchCardiovascular DiseaseAtherosclerosisSurgery	2009	816
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial John A. Ormiston, Patrick W. Serruys, Evelyn Regar, The Lancet Percutaneous Coronary InterventionProspective Open-label TrialCardiovascular DiseaseCoronary UnitSurgery	2008	714
Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction Harvey D. White, R M Norris, Michael Brown, New England Journal of Medicine	1987	620
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Journal of the American College of Cardiology Tissue EngineeringPercutaneous Coronary InterventionEngineeringEndovascular TechniqueCardiovascular Disease	2011	525
Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. John A. Ormiston, Pravin M. Shah, Chuwa Tei, Circulation Heart FailureMitral Annular ReconstructionSurgeryMitral Valve AnnulusDiastolic Function	1981	461
Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions Jean Fajadet, William Wijns, GertJan Laarman, Circulation	2006	461
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Circulation	2010	306
The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation. Chuwa Tei, J P Pilgrim, Pravin M. Shah, Circulation Normal SubjectsHeart FailureRadiologyTricuspid RegurgitationCardiovascular Disease	1982	248
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months Patrick W. Serruys, Yoshinobu Onuma, Héctor M. García‐García, EuroIntervention	2014	238
Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease Yoshinobu Onuma, Dariusz Dudek, Leif Thuesen, JACC: Cardiovascular Interventions Tissue EngineeringEngineeringCardiovascular DiseaseFive-year ClinicalCardiology	2013	214

Page 1